93 International Institute of Molecular and Cell Biology Staff Scientist positions at PhD Programme "Gene Regulation in Evolution"
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
sequencing, ATAC sequencing, and computational biology. Additional information on our research projects can be found in our recent publications, including Elife (2023) 12 . 10.7554/eLife.87306, International
-
system against cancer cells. The Chemoproteomics Team plays a vital role in this mission through enabling the discovery and molecular understanding of small-molecule therapeutics. We are seeking a
-
system against cancer cells. The Chemoproteomics Team plays a vital role in this mission through enabling the discovery and molecular understanding of small-molecule therapeutics. We are seeking a
-
of the Oncogenic Transcriptional Networks Group within the Cancer Cell Biology (CCB) Department. The candidate should have expertise in cell line engineering technologies, molecular and protein biology methods, and
-
science (e.g. biology, cell biology, immunology, virology, microbiology) or bioengineering/biomedical engineering with at least 3 years of experience or MA/MS degree with at least 1-2 years of laboratory
-
expertise in cancer cell biology. POSITION SUMMARY The successful candidate will be responsible for designing and executing preclinical discovery research activities in collaboration with cross functional
-
of the Oncogenic Transcriptional Networks Group within the Cancer Cell Biology (CCB) Department. The candidate should have expertise in cell line engineering technologies, molecular and protein biology methods, and
-
research with minimal supervision. Experience with human and murine neuronal cell culture and assay development Expertise in Lipid loading and related pathway analysis Expertise in core molecular biology
-
pathwaysand characterizing the molecular interactions between chemical compounds and target protein(s). As an AssociateScientist, you will be at the center of our operations and you'll find that everything we
-
, drug mechanisms-of-actions, and biomarkers. We are dedicated to the development of oncology agents that disrupt cancer biology or redirect the immune system against cancer cells, and we leverage